TXG possible reversalOversold on the daily, Filled Gap from Nov 2023, Risk is todays low 35.42. Rsi curl .
PT is open, had previous support at 40.40 which would be 1st resistance , SMA or fib levels also
−2.18USD
−255.10 MUSD
618.73 MUSD
98.51 M
About 10X GENOMICS INC COM USD0.00001 CLASS A
Sector
Industry
CEO
Serge Saxonov
Website
Headquarters
Pleasanton
Employees (FY)
1.26 K
Founded
2012
ISIN
US88025U1097
FIGI
BBG00ZNLFFH2
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
TXG approaching support zonesAnticipating support in these zones wont hurt. Keeping strict stop loss and following long trade has a higher probability to win
Best stock to buy nowBest stock to buy now - 23.05.2023
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genom
TXG Healthcare name we are shortA small position is suggested due to our stance on Healthcare being bullish and also the R isn't quite at 2.00 as of yet.
10X Genomics, Inc - Bullish divergenceOn the above 6-day chart price action has corrected 75% since the sell signal back in November 2020. A number of reasons now exist to be long, including:
1) Double ‘incredible buy’ signals. Awesome.
2) Price action and RSI resistance breakouts.
3) Price action is arrested by past support / resist
14/4/2022 NASDAQ (TXG)Short (Entry Price) within the sell zone area and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price.
Entry Price: $68.33 / $70.99
Target Price: $65.60 / $69.04
Stop Loss: $72.94
10x Genomics (NASDAQ: $TXG) Looks Ready For Growth! 🍄10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluid
TXG for an oversold bounceLong TXG 2,000 shares and 51 $110 Feb 18th calls. There has been some interesting call option activity on TXG as of last week 1/25/2022 someone purchased 600 Feb 18, 2022 $110 calls and 600 Feb 18, 2022 $120 calls and paid approximately $400k for these call options for a stock with little option ac
$TXG Double Bottom Setup$TXG working on a well defined double bottom base.
2 things grabbed my attention that made me pause while flipping through charts:
* Vol dry up while rounding up that 2nd bottom
* Pretty much pocket pivot after pocket pivot through out the rally from 2nd bottom(aggressive buying)
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0A88 is 28.75 USD — it has increased by 0.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange 10X GENOMICS INC COM USD0.00001 CLASS A stocks are traded under the ticker 0A88.
10X GENOMICS INC COM USD0.00001 CLASS A is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
0A88 stock is 2.27% volatile and has beta coefficient of 2.76. Check out the list of the most volatile stocks — is 10X GENOMICS INC COM USD0.00001 CLASS A there?
One year price forecast for 10X GENOMICS INC COM USD0.00001 CLASS A has a max estimate of 65.00 USD and a min estimate of 30.00 USD.
0A88 earnings for the last quarter are −0.79 USD per share, whereas the estimation was −0.46 USD resulting in a −71.58% surprise. The estimated earnings for the next quarter are −0.35 USD per share. See more details about 10X GENOMICS INC COM USD0.00001 CLASS A earnings.
10X GENOMICS INC COM USD0.00001 CLASS A revenue for the last quarter amounts to 153.64 M USD despite the estimated figure of 151.30 M USD. In the next quarter revenue is expected to reach 182.73 M USD.
Yes, you can track 10X GENOMICS INC COM USD0.00001 CLASS A financials in yearly and quarterly reports right on TradingView.
0A88 stock has fallen by 19.39% compared to the previous week, the month change is a 23.28% fall, over the last year 10X GENOMICS INC COM USD0.00001 CLASS A has showed a 45.86% decrease.
0A88 net income for the last quarter is −48.95 M USD, while the quarter before that showed −92.99 M USD of net income which accounts for 47.36% change. Track more 10X GENOMICS INC COM USD0.00001 CLASS A financial stats to get the full picture.
Today 10X GENOMICS INC COM USD0.00001 CLASS A has the market capitalization of 3.47 B, it has increased by 1.08% over the last week.
No, 0A88 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A88 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 10X GENOMICS INC COM USD0.00001 CLASS A stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.26 K employees. See our rating of the largest employees — is 10X GENOMICS INC COM USD0.00001 CLASS A on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 10X GENOMICS INC COM USD0.00001 CLASS A technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 10X GENOMICS INC COM USD0.00001 CLASS A stock shows the sell signal. See more of 10X GENOMICS INC COM USD0.00001 CLASS A technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on 10X GENOMICS INC COM USD0.00001 CLASS A future price: according to them, 0A88 price has a max estimate of 65.00 USD and a min estimate of 30.00 USD. Read a more detailed 10X GENOMICS INC COM USD0.00001 CLASS A forecast: see what analysts think of 10X GENOMICS INC COM USD0.00001 CLASS A and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 10X GENOMICS INC COM USD0.00001 CLASS A EBITDA is −160.73 M USD, and current EBITDA margin is −25.58%. See more stats in 10X GENOMICS INC COM USD0.00001 CLASS A financial statements.